Will Irish Eyes Still Be Smiling When Trump Tariffs Hits Pharma?

The US president's most recent comments suggest tariffs on pharma are imminent and Ireland has the most to lose.

The US pharmaceutical industry’s love affair with Ireland has been blooming for over half a century but if Donald Trump has his way, that beautiful friendship could end in tears.

Key Takeaways
  • Trump wants drugmakers to bring manufacturing back to the US, especially from Ireland
  • The Irish government is confident about the sector’s long-term future on the island

The sector got an initial reprieve when the US president exempted pharmaceuticals in his announcement last week of widespread double-digit tariffs on most goods imported to the country. However, Trump told attendees at an event at the National Republican Congressional Committee on 8 April that “we’re going to be announcing very shortly

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Manufacturing

More from Supply Chain